Xiamen Amoytop Biotech Co., Ltd. (SHA:688278)
China · Delayed Price · Currency is CNY 76.54
-1.32 (-1.70%)
Nov 17, 2025, 2:15 PM CST
Xiamen Amoytop Biotech Company Description
Xiamen Amoytop Biotech Co., Ltd. engages in research, development, production, and sale of recombinant protein drugs in China and internationally.
It offers various drug products, such as pegsomatropin injection, pegfilgrastim injection, molgramostim, filgrastim, and oprelvekin; active pharmaceutical ingredients (APIs); and reagents to treat viral hepatitis, malignant tumors, and immunotherapy.
Xiamen Amoytop Biotech Co., Ltd. was founded in 1996 and is headquartered in Xiamen, China.
Xiamen Amoytop Biotech Co., Ltd.
| Country | China |
| Founded | 1996 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 2,423 |
| CEO | Li Sun |
Contact Details
Address: No. 330 Wengjiao Road Xiamen, 361028 China | |
| Phone | 86 59 2688 9106 |
| Website | amoytop.com |
Stock Details
| Ticker Symbol | 688278 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100003RT3 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Li Sun | Chairman and GM |
| Yiling Yang | Chief Financial Officer, Accounting Supervisor, Deputy GM and Secretary |
| Liping Lai | Vice President and Director |
| Jiehua Zheng | Deputy General Manager |
| Weidong Zhou | Deputy General Manager |
| Linzhong Zhang | Deputy General Manager |
| Meihua Yang | Deputy General Manager |
| Liyu Shi | Deputy General Manager |